Brivaracetam powder
Synonym: UCB-34714;API-Anti Epilepsy;(alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
CAS NO.: 357336-20-0
EINECS NO.: 801-184-2
Molecular Formula: C11H20N2O2
Purity & Grade: 99%; Medicine grade
Character: White Powder
Free sample: Available
Stock: In stock
Warehouse: USA/EU/AU Warehouse
MOQ & Package: 50g; Package according to demand
Shipping: Safe and fast delivery
Lead Time: 7-15 days
Store & Shelf life: Cool & dry place; 24 months
- Product Description
Xi'an Faithful BioTech Co., Ltd: Your Trusted Brivaracetam powder Manufacturer & Supplier
Xi'an Faithful BioTech Co., Ltd. sells high quality Brivaracetam powder. The strength of our company does not lie in a single dimension of "large production capacity" or "low price", but in an integrated capability of "compliance + quality + technology + supply + service" built around "drug safety". For downstream formulation enterprises, choosing us is not merely about purchasing "powder raw materials", but also about obtaining a "long-term, safe and stable supply chain partner", ultimately ensuring the medication safety and treatment continuity of antiepileptic patients.
Brivaracetam powder Introduction
Brivaracetam powder has a high affinity and selectively binds to synaptic vesicle protein 2A(SV2A), which is the site of action of AED Levetiracetam. SV2A is located on the presynaptic membrane and participates in regulating the release of neurotransmitters and vesicle circulation, thereby maintaining the normal function of synaptic vesicles. The combination of AED and SV2A can reduce the release of excitatory neurotransmitters and control epileptic seizures by regulating the balance of excitatory and inhibitory neurotransmitters in the brain. The affinity of Brivaracetam is 15 to 30 times that of Levetiracetam, reducing its usage by approximately 10 times.
COA
| Test items | Specifications | Results |
| Appearance | Powder | Complies |
| Color | White powder | Complies |
| Particle Size | 100% pass 80 mesh | Complies |
| Oder | Characteristic | Complies |
| Taste | Characteristic | Complies |
| Loss on Drying | ≤5.0% | 2.20% |
| Residue on Ignition | ≤0.1% | 0.05% |
| Residual | ≤0.1% | Complies |
| Residual Ethanol | ≤0.5% | Complies |
| Heave Mentals | ≤10ppm | Complies |
| Na | ≤0.1% | <0.1% |
| Pb | ≤3 ppm | Complies |
| Total Plate | <1000CFU/g | Complies |
| Yeast & Mold | <100 CFU /g | Complies |
| E. Coli | Negative | Complies |
| Salmonella | Negative | Complies |
| Conclusion | Conform with enterprise specification | |
Why Choose Us?
Our product has a remarkable therapeutic effect: Brivaracetam is a new type of antiepileptic drug. It can selectively bind to central synaptic vesicle protein 2A (SV2A), reduce the release of excitatory neurotransmitters, and thereby effectively control epileptic seizures.
Good safety and tolerability: The adverse reactions of Brivaracetam are relatively mild, with the most common ones being drowsiness, dizziness, fatigue and nausea, etc. Serious adverse events are rare. Compared with other antiepileptic drugs, Brivaracetam has a relatively small impact on cognitive function and behavior, and is particularly suitable for long-term treatment.
Wide range of applicable population: Brivaracetam is suitable for partial seizures in adults and children with epilepsy aged 1 month and above. Both adult and child patients can be treated with this drug under the guidance of a doctor, providing a new treatment option for epilepsy patients of different age groups.
Application Areas
Brivaracetam is an antiepileptic drug with a core application in the treatment of epilepsy. It is specifically used as an adjuvant or monotherapy for partial seizures (with or without secondary generalized seizures) in adult and pediatric patients over one month old. It controls epileptic seizures by regulating the release of neurotransmitters and improves the symptoms of patients.
Quality Control:
R&D Results:
Packaging and Transportation:
After-Sales Service:
Qualification Certification:
Transaction Feedback:
Exhibition:
FAQ
Q1: What is Brivaracetam powder used to treat?
A1: Brivaracetam is used to help control partial onset seizures in the treatment of epilepsy. It cannot cure epilepsy and will only work to control seizures for as long as you continue to use it.
Q2: How quickly does Brivaracetam powder work?
A2: Brivaracetam starts to work after your first dose. Because of how the drug works, you likely won't feel the drug working in your body. But your doctor will monitor you during treatment to check whether the drug is working to treat your condition.
Q3: Can you stop Brivaracetam powder?
A3: Your doctor may do a blood test to check the blood counts a few weeks after you start the medication. However, once the patient is stable on Brivaracetam, ongoing blood tests are usually not required. Brivaracetam cannot be stopped suddenly – withdrawal of the medication needs to be supervised by your doctor.
Contact Us
Ready to place an immediate order for Brivaracetam powder? Feel free to contact us through email: sales9@faithfulbio.com. As soon as we receive your message, we’ll get back to you quickly regarding your desired purchase quantity, shipping specifics and other related needs.
Let's work together to turn your goals into reality.
